Radiology News: Nuclear Medicine p5 Result Pages • 'Nuclear medicine specialists are feeling the brunt of increased public anxiety and regulatory concern regarding patient radiation exposures. Nuclear cardiologists, in particular, find themselves in the crosshairs as a result of recent evidence of ...' Wednesday, 12 October 2011 by www.familypracticenews.com • 'International Isotopes Inc. (OTC Bulletin Board: INIS) announces financial results for the second quarter and six-months ended June 30, 2011. Revenue for the three-month period ended June 30, 2011, was $2,614,744, as compared to $1,485,293 for the ...' Thursday, 11 August 2011 by www.sys-con.com • 'After witnessing a downtrend for several years, revenues in the U.S. nuclear medicine and PET imaging systems market finally pivoted in 2010. New radiotracers and technologies are expanding the clinical scope and customer base of nuclear medicine and PET ...' Wednesday, 29 June 2011 by www.businesswire.com • 'Russian State Atomic Energy Corporation ROSATOM and Royal Philips Electronics (AEX: PHI, NYSE: PHG) have announced their intention to develop a nuclear medicine industry ecosystem in Russia. Nuclear medicine is an important medical imaging technique used ...' Friday, 24 June 2011 by www.ehealthnews.eu • Research and Markets: Molybdenum-99, Privatising Nuclear Medicine: Need for Continuous Supplies of Medical Isotopes Means Transforming Molybdenum-99 to a Lucrative Commodity 'This Special Report from Business Monitor International examines the global supply of Molybdenum- 99, looking at the likelihood of price rises and the implications of investment. Molybdenum-99 is a radioisotope primarily produced from the nuclear ...' Friday, 24 June 2011 by www.businesswire.com • 'Patients undergoing molecular imaging to evaluate their stomach's ability to clear food are going to have an altogether new kind of breakfast. A study presented at SNM's 58th Annual Meeting has confirmed that nuclear medicine technologists can ...' Monday, 6 June 2011 by www.eurekalert.org • Phase 3 Lymphoseek (Tilmanocept) Study Results Featured at Society of Nuclear Medicine Annual Meeting 'Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that full results from the NEO3-05 study, demonstrating Lymphoseek® (99mTc-tilmanocept) met all primary and secondary ...' Monday, 6 June 2011 by www.businesswire.com • 'Dilon Diagnostics will introduce the latest advancement in molecular breast imaging (MBI) this week at the Society of Nuclear Medicine (SNM) Meeting in San Antonio, Texas, with the premiere of its FDA-cleared Dilon 6800® Acella Gamma Camera system. To ...' Thursday, 2 June 2011 by www.prnewswire.com • 'Scint-X (Stockholm, Sweden), developer of a unique x-ray scintillator device, has secured $1.6 million (SEK 10 Million) in growth capital from Conor Venture Partners and STING Capital. The company will use the funds to grow its business on the ...' Monday, 2 May 2011 by www.vision-systems.com • Lantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease 'Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design and planned analysis of a ...' Friday, 11 March 2011 by www.businesswire.com Result Pages The most beautiful thing we can experience is the mysterious. It is the source of all true art and science. - Albert Einstein |